NRIP1: A Potential Drug Target for Cancer (G8204)

Target Name: NRIP1

NCBI ID: G8204

NRIP1

NRIP1: A Potential Drug Target for Cancer

Nuclear factor RIP140 (NRIP1) is a protein that plays a critical role in cellular signaling pathways. It is a key regulator of the DNA damage response, which is a critical process that helps the cell repair itself after a DNA molecule is damaged or deleted. NRIP1 is also involved in the regulation of cell adhesion, and has been shown to play a role in the development and progression of various diseases, including cancer.

NRIP1 is a nuclear protein that is composed of two subunits: a protein that contains 264 amino acids (NRIP1伪) and a protein that contains 154 amino acids (NRIP1尾). NRIP1伪 is the catalytic subunit, while NRIP1尾 is the regulatory subunit. of NRIP1 are held together by a disulfide bond, which is a covalent bond that joins two amino acids that are involved in the interaction between the subunits.

NRIP1 is a key regulator of the DNA damage response. During DNA damage, the double helix of DNA is broken, and the cell needs to repair the damage. NRIP1 is involved in the regulation of the repair process, ensuring that the repair is carried out correctly and that the cell is able to withstand the damage.

One of the key functions of NRIP1 is its role in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues.NRIP1 is involved in the regulation of cell adhesion by ensuring that cells stick together properly and that the cell -cell adhesion is strong enough to support the growth and development of tissues.

NRIP1 is also involved in the regulation of cell signaling pathways. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival. NRIP1 is also involved in the regulation of the TGF -尾 signaling pathway, which is involved in the regulation of cell growth and differentiation.

NRIP1 is a potential drug target and biomarker for various diseases, including cancer. Its involvement in the regulation of the DNA damage response and cell signaling pathways makes it an attractive target for researchers looking for new treatments for these diseases.

NRIP1 is a protein that plays a critical role in cellular signaling pathways. It is involved in the regulation of the DNA damage response, cell adhesion, and cell signaling pathways. Because it plays an important role in these processes, NRIP1 is a potential drug target and biomarker for various diseases, including cancer.

Protein Name: Nuclear Receptor Interacting Protein 1

Functions: Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. Involved in the regulation of ovarian function (By similarity). Plays a role in renal development (PubMed:28381549)

The "NRIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets